Monroe Capital acted as joint lead arranger on the funding of a senior credit facility to support the acquisition of PAI Pharma (“PAI”) by Olympus Partners.
Founded in 1968 and based in Greenville, SC, PAI is a leading US oral generic liquids manufacturer of ready-to-dose cups and oral liquids bottles. PAI offers the broadest portfolio of generic oral liquid medicines in the industry, supporting retail chains, independent pharmacies, hospitals, long-term care facilities and government agencies.